Natural Heart Health Supplement Trial
Part of paid clinical trials in New York, New York.
- Sponsor
- Efforia, Inc
- Study ID
- NCT06671769
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cholesterol
- Cholesterol (total and HDL)
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Heart Health Supplement — DIETARY_SUPPLEMENTThis is a natural heart health supplement in powdered format, chocolate flavor where participants will take a daily dose.
Study Details
We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP).
Key Dates
- Start date
- Jan 15, 2025
- Status verified
- Nov 2024
- Primary completion
- Apr 30, 2025
- Completion
- May 1, 2025
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Natural Heart Health Dietary Supplement in Chocolate Powder Forma natural heart-health dietary supplement in chocolate powder form designed to be taken daily.
Primary Outcome Measure
Total Cholesterol [ Time Frame: from Baseline to 30 day and 90 day. ]
Central Contacts
- Matthew Amsden(646) 679-2479
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Efforia - Study will be entirely online | New York | New York | 10003 | - |
Find similar trials in New York, NY
By research site
Related Studies
- Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)EARLY_PHASE1 · Recruiting · Benjamin Viglianti · Ann Arbor, Michigan
- Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)EARLY_PHASE1 · Recruiting · Benjamin Viglianti · Ann Arbor, Michigan
- Health-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthNot Yet Recruiting · Yale University · New Haven, Connecticut
- Interprofessional Pharmacogenomics (IPGx) Registry and RepositoryRecruiting · Texas A&M University · Bryan, Texas